1. MiR-200 family and cancer: From a meta-analysis view
- Author
-
Huiyuan Cao, George A. Calin, Yuke Liu, Yan Lu, Guo Liang Huang, Jiancong Sun, and Huanyu Zhang
- Subjects
0301 basic medicine ,Oncology ,medicine.medical_specialty ,Clinical Biochemistry ,Biochemistry ,Cancer prognosis ,03 medical and health sciences ,0302 clinical medicine ,Neoplasms ,Internal medicine ,microRNA ,medicine ,Humans ,Molecular Biology ,Proportional Hazards Models ,Oncogene ,business.industry ,Hazard ratio ,Cancer ,General Medicine ,medicine.disease ,Survival Analysis ,Confidence interval ,MicroRNAs ,030104 developmental biology ,030220 oncology & carcinogenesis ,Meta-analysis ,Molecular Medicine ,Cancer development ,business - Abstract
The role of microRNAs (miRNAs) in cancer development was implicated as oncogene or tumor suppressor. One of the miRNA family, the miR-200 family, was mainly characterized as tumor suppressor. However, controversial results were reported. The associations between miR-200 family (consisting of five miRNAs: miR-141/200a/200b/200c/429) and cancer prognosis were inconsistent. Therefore, we conducted a meta-analysis by searching PubMed and Embase databases for studies assessing the association between the expression of miR-200 family and patients' survival of cancers. Hazard ratios (HRs) with 95% confidence intervals (CIs) were extracted from the studies and pooled HRs was determined to evaluate the association. This meta-analysis comprised 58 articles with 8107 cancer patients. The overall analysis showed that patients with higher expression of miR-200 family were associated with worse survival (HR = 1.206, 95% CI: 1.115-1.305, p 0.001). In the stratified analysis, high level of miR-200b and miR-200c was associated with poor patients' survival. In the subgroup analysis, expression of miR-200a and miR-429 was associated with survival of breast cancer and liver cancer, respectively. Expression of miR-141 was found to be associated with favorable patients' survival in pancreatic cancer (HR = 0.275, 95% CI: 0.104-0.727, p = 0.009). In the subgroup analysis of sample type of miR-141, reverse associations with patients' survival were found from tissue (HR = 0.769, 95% CI: 0.597-0.990, p = 0.042) and blood (HR = 1.496, 95% CI: 1.183-1.893, p = 0.001). Our findings revealed that association between miR-200 family and prognosis of various cancer types was significant and the results needed specific interpretation.
- Published
- 2019